SCHEMBL26734865

SCHEMBL26734865

CCCCCCCCCCCCN(CCC)CCCCCCCCCCCC(=O)OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 5/20 0.55
▸ PHF8 Q9UPP1 2/20 0.51
▸ KDM4C Q9H3R0 1/20 0.51
▸ DNM1 Q05193 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ POLA1 P09884 1/20 0.49
▸ DGKA P23743 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CA14 Q9ULX7 1/20 0.46
▸ LMNA P02545 3/20 0.46
▸ EPHX2 P34913 1/20 0.45
▸ PAM P19021 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ ICMT O60725 1/20 0.44
▸ ALB P02768 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13903730 0.96 KDM5A (0.58) KDM5APHF8KDM4CDNM1POLB
SCHEMBL11800393 0.93 KDM5A (0.54) KDM5APHF8KDM4CDNM1POLB
SCHEMBL19032415 0.90 KDM5A (0.52) KDM5APHF8KDM4CDNM1POLB
SCHEMBL18641632 0.90 KDM5A (0.52) KDM5APHF8KDM4CDNM1POLB
SCHEMBL20623310 0.90 KDM5A (0.52) KDM5APHF8KDM4CDNM1POLB
SCHEMBL8954639 0.89 KDM5A (0.58) KDM5APHF8KDM4CDNM1POLB
SCHEMBL16922400 0.89 KDM5A (0.58) KDM5APHF8KDM4CDNM1POLB
SCHEMBL8954715 0.89 KDM5A (0.58) KDM5APHF8KDM4CDNM1POLB
SCHEMBL10352448 0.89 KDM5A (0.58) KDM5APHF8KDM4CDNM1POLB
SCHEMBL17451524 0.89 TSHR (0.61) KDM5APHF8KDM4CDNM1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346907-A1 SEXUALLY TRANSMITTED DISEASE VACCINES MODERNATX, INC. (US) 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230346907-A1 SEXUALLY TRANSMITTED DISEASE VACCINES DIS3, KLK3, RTCB KDM5A 3575/4885PHF8 2969/4885KDM4C 3111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback